_version_ 1827376679348076544
author Iris A. Bermejo
Ana Guerreiro
Ander Eguskiza
Nuria Martínez-Sáez
Foivos S. Lazaris
Alicia Asín
Víctor J. Somovilla
Ismael Compañón
Tom K. Raju
Srdan Tadic
Pablo Garrido
Josune García-Sanmartín
Vincenzo Mangini
Ana S. Grosso
Filipa Marcelo
Alberto Avenoza
Jesús H. Busto
Fayna García-Martín
Ramón Hurtado-Guerrero
Jesús M. Peregrina
Gonçalo J. L. Bernardes
Alfredo Martínez
Roberto Fiammengo
Francisco Corzana
author_facet Iris A. Bermejo
Ana Guerreiro
Ander Eguskiza
Nuria Martínez-Sáez
Foivos S. Lazaris
Alicia Asín
Víctor J. Somovilla
Ismael Compañón
Tom K. Raju
Srdan Tadic
Pablo Garrido
Josune García-Sanmartín
Vincenzo Mangini
Ana S. Grosso
Filipa Marcelo
Alberto Avenoza
Jesús H. Busto
Fayna García-Martín
Ramón Hurtado-Guerrero
Jesús M. Peregrina
Gonçalo J. L. Bernardes
Alfredo Martínez
Roberto Fiammengo
Francisco Corzana
author_sort Iris A. Bermejo
collection DOAJ
first_indexed 2024-03-08T12:26:23Z
format Article
id doaj.art-874bf93e2a424c2dad381e2f8402117f
institution Directory Open Access Journal
issn 2691-3704
language English
last_indexed 2024-03-08T12:26:23Z
publishDate 2023-11-01
publisher American Chemical Society
record_format Article
series JACS Au
spelling doaj.art-874bf93e2a424c2dad381e2f8402117f2024-01-22T08:41:08ZengAmerican Chemical SocietyJACS Au2691-37042023-11-014115016310.1021/jacsau.3c00587Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable ResponsesIris A. Bermejo0Ana Guerreiro1Ander Eguskiza2Nuria Martínez-Sáez3Foivos S. Lazaris4Alicia Asín5Víctor J. Somovilla6Ismael Compañón7Tom K. Raju8Srdan Tadic9Pablo Garrido10Josune García-Sanmartín11Vincenzo Mangini12Ana S. Grosso13Filipa Marcelo14Alberto Avenoza15Jesús H. Busto16Fayna García-Martín17Ramón Hurtado-Guerrero18Jesús M. Peregrina19Gonçalo J. L. Bernardes20Alfredo Martínez21Roberto Fiammengo22Francisco Corzana23Department of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, PortugalDepartment of Biotechnology, University of Verona, Verona, ItalyDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, SpainAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, SpainAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, SpainAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, SpainCenter for Biomolecular Nanotechnologies@UniLe, Istituto Italiano di Tecnologia (IIT), Lecce, ItalyApplied Molecular Biosciences Unit UCIBIO, Department of Chemistry, NOVA School of Science and Technology, Caparica, PortugalApplied Molecular Biosciences Unit UCIBIO, Department of Chemistry, NOVA School of Science and Technology, Caparica, PortugalDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainInstitute of Biocomputation and Physics of Complex Systems, University of Zaragoza, Zaragoza, SpainDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, SpainInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, PortugalAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, SpainDepartment of Biotechnology, University of Verona, Verona, ItalyDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño, Spainhttps://doi.org/10.1021/jacsau.3c00587
spellingShingle Iris A. Bermejo
Ana Guerreiro
Ander Eguskiza
Nuria Martínez-Sáez
Foivos S. Lazaris
Alicia Asín
Víctor J. Somovilla
Ismael Compañón
Tom K. Raju
Srdan Tadic
Pablo Garrido
Josune García-Sanmartín
Vincenzo Mangini
Ana S. Grosso
Filipa Marcelo
Alberto Avenoza
Jesús H. Busto
Fayna García-Martín
Ramón Hurtado-Guerrero
Jesús M. Peregrina
Gonçalo J. L. Bernardes
Alfredo Martínez
Roberto Fiammengo
Francisco Corzana
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
JACS Au
title Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
title_full Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
title_fullStr Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
title_full_unstemmed Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
title_short Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
title_sort structure guided approach for the development of muc1 glycopeptide based cancer vaccines with predictable responses
url https://doi.org/10.1021/jacsau.3c00587
work_keys_str_mv AT irisabermejo structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT anaguerreiro structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT andereguskiza structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT nuriamartinezsaez structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT foivosslazaris structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT aliciaasin structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT victorjsomovilla structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT ismaelcompanon structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT tomkraju structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT srdantadic structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT pablogarrido structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT josunegarciasanmartin structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT vincenzomangini structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT anasgrosso structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT filipamarcelo structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT albertoavenoza structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT jesushbusto structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT faynagarciamartin structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT ramonhurtadoguerrero structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT jesusmperegrina structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT goncalojlbernardes structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT alfredomartinez structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT robertofiammengo structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses
AT franciscocorzana structureguidedapproachforthedevelopmentofmuc1glycopeptidebasedcancervaccineswithpredictableresponses